Implication for health policy/practice/research/medical education:
In the last decade, there has been an increasing interest in the exact role of intravenous rituximab in the management of ANCAassociated vasculitis presenting with severe acute kidney injury. We describe a recent experience at The Robert Larner, M.D.
College of Medicine, University of Vermont, Burlington, VT, USA that enabled us to revisit this controversy. There is indeed a
place for rituximab in combination with glucocorticoids in these circumstances.
Please cite this paper as: Onuigbo M, Seok J, Anyamene I, Ejimone F, Eze-Raphael C, Vanessa Park IA. Rituximab in ANCAassociated vasculitis presenting with severe acute kidney injury; a case report. J Nephropharmacol. 2019;8(1):e13. DOI: 10.15171/